Daha iyi bir deneyim için konum izni vermelisiniz.
MENU
ÖZGEÇMİŞ
ÜYELİKLER
BİLİMSEL YAYINLAR
EĞİTİM
  • 2006 Gazi Üniversitesi Tıp Fakültesi Kardiyoloji
  • 1999 Hacettepe Üniversitesi
İŞ DENEYİMİ
  • 2014 - Halen Acıbadem Sağlık Grubu
  • 2012 - 2014 Memorial Şişli Hastanesi, İstanbul
  • 2010 - 2015 London School of Hygiene & Tropical Medicine, University of London
  • 2009 - 2012 Clinical Trials and Evaluation Unit, Royal Brompton Hospital, London, Imperial College, United Kingdom
  • 2007 Ankara Yüksek İhtisas Eğitim ve Araştırma Hastanesi
  • 2006 - 2008 Kırıkkale Yüksek İhtisas Hastanesi
  • 2004 Cleveland Clinic Foundation, Ohio, USA
  • 2000 - 2006 Gazi Üniversitesi Tıp Fakültesi Kardiyoloji Anabilim Dalı
ÜYELİKLER
  • Türk Tabipler Birliği
  • Türk Kardiyoloji Derneği
  • European Society of Cardiology Heart Failure Association
  • European Society of Cardiology Working Group on Grown-up Congenital Heart Disease
  • European Society of Cardiology (Fellow)
BİLİMSEL YAYINLAR
  • Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists'' Collaboration. American Heart Journal (online 12 Feb 2014) Pitcher A, Emberson J, Lacro RV et al.
  • Severe hypokalemia probably associated with sertraline use. Ann Pharmacother. 2014 Feb;48(2):297-300 Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F.
  • Beta-Blockers in Heart Failure Collaborative Group. Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design. Syst Rev. 2013 Jan 18;2:7 Kotecha D, Manzano L, Altman DG, Krum H, Erdem G, Williams N, Flather MD
  • Rates and causes of death from non-ST elevation acute coronary syndromes: ten year follow-up of the PRAIS-UK registry. Int J Cardiol. 2013 Sep 20;168(1):490-4 Erdem G, Bakhai A, Taneja AK, Collinson J, Banya W, Flather MD.
  • A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of irbesartan on aortic dilatation in Marfan syndrome (AIMS trial): study protocol. Trials. 2013 Dec 1;14:408 Mullen MJ, Flather MD, Jin XY, Newman WG, Erdem G, Gaze D, Valencia O, Banya W, Foley CE, Child A.
  • How should I treat an ostial thrombotic occlusion of the right coronary artery in the setting of an acute myocardial infarction? EuroIntervention. 2012 Jun 20;8(2):282-9 Izgi C, Feray H, Erdem G, Bakal RB, de Smet B, Pundziute G, Mamas MA.
  • Assessing bleeding risk in acute coronary syndromes. Rev Esp Cardiol (Engl Ed). 2012 Jan;65(1):4-6 Erdem G, Flather M.
  • What goes into a major acute coronary syndrome trial and what will future trials look like? Curr Cardiol Rep. 2010 Jul;12(4):348-55 Erdem G, Geisler T, Flather MD.
  • Thrombolysis in myocardial infarction frame count in coronary arteries without visible atherosclerosis incoronary angiography of patients with stable coronary artery disease. Saudi Med J. 2009 Jun;30(6):817-20 Tacoy GA, Yazici GE, Kocaman SA, Ozdemir MH.
  • The optimal time of elective percutaneous coronary intervention for stable patients after ST elevation myocardial infarction. Angiology. 2009 Feb-Mar;60(1):67-73 Yazici GE, Erden M, Tacoy GA, Yavuz BB, Turkoglu S, Timurkaynak T.
Daha iyi bir deneyim için konum izni vermelisiniz.
Size nasıl yardımcı olabiliriz?